Published in J Bacteriol on April 01, 1997
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother (1999) 4.29
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
Insect-microbe mutualism without vertical transmission: a stinkbug acquires a beneficial gut symbiont from the environment every generation. Appl Environ Microbiol (2007) 2.66
Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. Appl Environ Microbiol (2007) 2.40
Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun (2006) 2.24
The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun (2011) 2.00
Biodefense-driven murine model of pneumonic melioidosis. Infect Immun (2003) 1.85
Flagella are virulence determinants of Burkholderia pseudomallei. Infect Immun (2003) 1.83
The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun (2005) 1.75
Versatile dual-technology system for markerless allele replacement in Burkholderia pseudomallei. Appl Environ Microbiol (2009) 1.74
Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun (2004) 1.70
Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun (1999) 1.70
Interaction between Burkholderia pseudomallei and Acanthamoeba species results in coiling phagocytosis, endamebic bacterial survival, and escape. Infect Immun (2000) 1.61
Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect Immun (2006) 1.54
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother (2010) 1.50
Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b. J Bacteriol (2004) 1.46
Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun (2002) 1.46
Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One (2012) 1.43
Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. J Bacteriol (2002) 1.36
Strategies for Intracellular Survival of Burkholderia pseudomallei. Front Microbiol (2011) 1.35
A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo. Infect Immun (2005) 1.34
Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis (2009) 1.34
Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei. J Bacteriol (1999) 1.29
Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei. J Bacteriol (2008) 1.27
Burkholderia pseudomallei, B. thailandensis, and B. ambifaria produce 4-hydroxy-2-alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. J Bacteriol (2008) 1.27
An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei. Gene (2008) 1.26
A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infect Immun (2010) 1.26
Molecular and physical characterization of Burkholderia mallei O antigens. J Bacteriol (2002) 1.26
Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei. Front Microbiol (2011) 1.25
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother (1999) 1.25
CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infect Immun (2006) 1.21
Invasion of spores of the arbuscular mycorrhizal fungus Gigaspora decipiens by Burkholderia spp. Appl Environ Microbiol (2003) 1.20
The role of the bacterial flagellum in adhesion and virulence. Biology (Basel) (2013) 1.15
Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis. Infect Immun (2006) 1.15
Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun (1997) 1.14
Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One (2010) 1.13
Variation in flagellin genes and proteins of Burkholderia cepacia. J Bacteriol (1998) 1.13
Glyphosate resistance as a novel select-agent-compliant, non-antibiotic-selectable marker in chromosomal mutagenesis of the essential genes asd and dapB of Burkholderia pseudomallei. Appl Environ Microbiol (2009) 1.09
Burkholderia thailandensis harbors two identical rhl gene clusters responsible for the biosynthesis of rhamnolipids. BMC Microbiol (2009) 1.08
Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrob Agents Chemother (2010) 1.08
In vivo Himar1 transposon mutagenesis of Burkholderia pseudomallei. Appl Environ Microbiol (2008) 1.08
Development of Burkholderia mallei and pseudomallei vaccines. Front Cell Infect Microbiol (2013) 1.08
Specific and sensitive detection of Ralstonia solanacearum in soil on the basis of PCR amplification of fliC fragments. Appl Environ Microbiol (2003) 1.07
Strategies for PCR based detection of Burkholderia pseudomallei DNA in paraffin wax embedded tissues. Mol Pathol (2002) 1.05
Sequence-defined transposon mutant library of Burkholderia thailandensis. MBio (2013) 1.03
Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages. Infect Immun (2009) 1.03
In vitro activity of BAL30072 against Burkholderia pseudomallei. Int J Antimicrob Agents (2011) 1.01
Flagellum-mediated adhesion by Burkholderia pseudomallei precedes invasion of Acanthamoeba astronyxis. Infect Immun (2003) 1.01
Stable, site-specific fluorescent tagging constructs optimized for burkholderia species. Appl Environ Microbiol (2010) 0.99
Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One (2012) 0.97
Evaluation of surrogate animal models of melioidosis. Front Microbiol (2010) 0.95
Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops). Infect Immun (2012) 0.93
Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Front Cell Infect Microbiol (2012) 0.93
Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis. J Bacteriol (2011) 0.92
Recombinant truncated flagellin of Burkholderia pseudomallei as a molecular probe for diagnosis of melioidosis. Clin Diagn Lab Immunol (2003) 0.91
Caspase-1-dependent and -independent cell death pathways in Burkholderia pseudomallei infection of macrophages. PLoS Pathog (2014) 0.91
Bactobolin resistance is conferred by mutations in the L2 ribosomal protein. MBio (2012) 0.90
Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. PLoS One (2013) 0.89
Engineering of tellurite-resistant genetic tools for single-copy chromosomal analysis of Burkholderia spp. and characterization of the Burkholderia thailandensis betBA operon. Appl Environ Microbiol (2009) 0.89
The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infect Immun (2011) 0.89
Plant-associated symbiotic Burkholderia species lack hallmark strategies required in mammalian pathogenesis. PLoS One (2014) 0.88
In vitro activity of cethromycin against Burkholderia pseudomallei and investigation of mechanism of resistance. J Antimicrob Chemother (2010) 0.88
Isolation and characterization of Burkholderia cenocepacia mutants deficient in pyochelin production: pyochelin biosynthesis is sensitive to sulfur availability. J Bacteriol (2004) 0.88
Identification of potential CepR regulated genes using a cep box motif-based search of the Burkholderia cenocepacia genome. BMC Microbiol (2006) 0.88
The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates. Antimicrob Agents Chemother (2013) 0.87
DISCRIMINATION OF Burkholderia mallei/pseudomallei FROM Burkholderia thailandensis BY SEQUENCE COMPARISON OF A FRAGMENT OF THE RIBOSOMAL PROTEIN S21 (RPSU) GENE. Eur J Microbiol Immunol (Bp) (2012) 0.87
The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacy. Antimicrob Agents Chemother (2013) 0.87
Burkholderia mallei and Burkholderia pseudomallei cluster 1 type VI secretion system gene expression is negatively regulated by iron and zinc. PLoS One (2013) 0.87
Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Infect Immun (2013) 0.86
Genes that influence swarming motility and biofilm formation in Variovorax paradoxus EPS. PLoS One (2012) 0.86
Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation. Infect Immun (2016) 0.85
Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM. Infect Immun (2014) 0.84
Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis (2013) 0.84
Survival of Burkholderia pseudomallei in water. BMC Res Notes (2008) 0.84
Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. PLoS One (2012) 0.84
rpsU-based discrimination within the genus Burkholderia. Eur J Microbiol Immunol (Bp) (2014) 0.84
Requirement of DNA repair mechanisms for survival of Burkholderia cepacia G4 upon degradation of trichloroethylene. Appl Environ Microbiol (2001) 0.84
Competition between Burkholderia pseudomallei and B. thailandensis. BMC Microbiol (2015) 0.83
Substituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomallei. Antimicrob Agents Chemother (2013) 0.83
Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells. Front Cell Infect Microbiol (2015) 0.83
Development of novel O-polysaccharide based glycoconjugates for immunization against glanders. Front Cell Infect Microbiol (2012) 0.83
The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis. BMC Microbiol (2012) 0.83
A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages. BMC Microbiol (2014) 0.83
Knockout and pullout recombineering for naturally transformable Burkholderia thailandensis and Burkholderia pseudomallei. Nat Protoc (2011) 0.82
Characterization and analysis of the Burkholderia pseudomallei BsaN virulence regulon. BMC Microbiol (2014) 0.81
Gene and protein expression in response to different growth temperatures and oxygen availability in Burkholderia thailandensis. PLoS One (2014) 0.81
Burkholderia mallei and Burkholderia pseudomallei stimulate differential inflammatory responses from human alveolar type II cells (ATII) and macrophages. Front Cell Infect Microbiol (2012) 0.80
Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker. PLoS One (2011) 0.80
Functional characterization of Burkholderia pseudomallei trimeric autotransporters. Infect Immun (2013) 0.80
When it comes to drug discovery not all Gram-negative bacterial biodefence pathogens are created equal: Burkholderia pseudomallei is different. Microb Biotechnol (2012) 0.79
DNA methylation in lysogens of pathogenic Burkholderia spp. requires prophage induction and is restricted to excised phage DNA. J Bacteriol (2005) 0.79
A functional gltB gene is essential for utilization of acidic amino acids and expression of periplasmic glutaminase/asparaginase (PGA) by Pseudomonas putida KT2440. Mol Genet Genomics (2003) 0.78
The chemical arsenal of Burkholderia pseudomallei is essential for pathogenicity. J Am Chem Soc (2014) 0.78
Sequence polymorphism and PCR-restriction fragment length polymorphism analysis of the flagellin gene of Burkholderia pseudomallei. J Clin Microbiol (2010) 0.77
An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens. Am J Trop Med Hyg (2013) 0.76
Altered Proteome of Burkholderia pseudomallei Colony Variants Induced by Exposure to Human Lung Epithelial Cells. PLoS One (2015) 0.76
Thermoregulation of biofilm formation in Burkholderia pseudomallei is disrupted by mutation of a putative diguanylate cyclase. J Bacteriol (2016) 0.76
Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response. PLoS Negl Trop Dis (2017) 0.76
Immune Modulation as an Effective Adjunct Post-exposure Therapeutic for B. pseudomallei. PLoS Negl Trop Dis (2016) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science (1995) 68.34
The winds of (evolutionary) change: breathing new life into microbiology. J Bacteriol (1994) 10.00
Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol (1994) 9.16
Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis (1989) 8.24
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol (1992) 6.40
The operon that encodes the sigma subunit of RNA polymerase also encodes ribosomal protein S21 and DNA primase in E. coli K12. Cell (1983) 5.73
Flagellin A is essential for the virulence of Vibrio anguillarum. J Bacteriol (1996) 5.38
New derivatives of transposon Tn5 suitable for mobilization of replicons, generation of operon fusions and induction of genes in gram-negative bacteria. Gene (1989) 4.64
The covalent structure of the phase-1 flagellar filament protein of Salmonella typhimurium and its comparison with other flagellins. J Biol Chem (1985) 4.11
Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol (1989) 3.57
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Alternative sigma factors and the regulation of flagellar gene expression. Mol Microbiol (1991) 3.53
DNA sequence analysis suggests that expression of flagellar and chemotaxis genes in Escherichia coli and Salmonella typhimurium is controlled by an alternative sigma factor. Proc Natl Acad Sci U S A (1987) 3.53
Structural and functional analysis of two Campylobacter jejuni flagellin genes. J Biol Chem (1990) 3.51
How bacteria sense and swim. Annu Rev Microbiol (1995) 3.14
Applications of network BLAST server. Methods Enzymol (1996) 3.03
Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK. J Bacteriol (1990) 3.01
The Bacillus subtilis flagellin gene (hag) is transcribed by the sigma 28 form of RNA polymerase. J Bacteriol (1989) 3.00
Cloning and genetic characterization of a Helicobacter pylori flagellin gene. Mol Microbiol (1992) 2.97
Genomic organization and expression of Campylobacter flagellin genes. J Bacteriol (1990) 2.95
Effects of galU mutation on flagellar formation in Escherichia coli. J Bacteriol (1977) 2.93
Nucleotide sequence of the hag gene encoding flagellin of Escherichia coli. J Bacteriol (1986) 2.68
Evidence for posttranslational modification and gene duplication of Campylobacter flagellin. J Bacteriol (1989) 2.65
Regions of Salmonella typhimurium flagellin essential for its polymerization and excretion. J Bacteriol (1987) 2.35
Identification and sequence analysis of two related flagellin genes in Rhizobium meliloti. J Bacteriol (1989) 2.05
Interaction of insulin with Pseudomonas pseudomallei. Infect Immun (1993) 1.95
Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94
Functions of bacterial flagella. Crit Rev Microbiol (1996) 1.92
Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun (1994) 1.77
Preventing the synthesis of unused transcripts by Rho factor. Cell (1991) 1.75
Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product. J Bacteriol (1991) 1.66
Cloning and sequencing of a Treponema pallidum gene encoding a 31.3-kilodalton endoflagellar subunit (FlaB2). Infect Immun (1989) 1.63
Molecular cloning of two Pseudomonas flagellin genes and basal body structural genes. Microbiology (1994) 1.62
Construction and use of a self-cloning promoter probe vector for gram-negative bacteria. Gene (1993) 1.59
Co-ordinate, temperature-sensitive regulation of the three Yersinia enterocolitica flagellin genes. Mol Microbiol (1995) 1.56
Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J Clin Microbiol (1990) 1.54
Cloning, sequencing, and expression of two class B endoflagellar genes of Treponema pallidum subsp. pallidum encoding the 34.5- and 31.0-kilodalton proteins. Infect Immun (1990) 1.54
Escherichia coli fliAZY operon. J Bacteriol (1996) 1.52
Cloning and genetic characterization of the flagellum subunit gene (flaA) of Legionella pneumophila serogroup 1. Infect Immun (1995) 1.47
Molecular characterization of intact, but cryptic, flagellin genes in the genus Shigella. Mol Microbiol (1994) 1.39
Cloning and characterization of a gene encoding flagellin of Listeria monocytogenes. Mol Microbiol (1992) 1.35
Cloning and nucleotide sequence of a flagellin-coding gene (hag) from Serratia marcescens 274. Gene (1989) 1.32
Expression of the flagellin gene in Borrelia is controlled by an alternative sigma factor. Microbiology (1995) 1.29
Conservation and evolution of the rpsU-dnaG-rpoD macromolecular synthesis operon in bacteria. Mol Microbiol (1993) 1.28
Cloning, nucleotide sequence, and taxonomic implications of the flagellin gene of Roseburia cecicola. J Bacteriol (1988) 1.27
Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. Gene (1994) 1.23
Identification of two expressed flagellin genes in the insect pathogen Bacillus thuringiensis subsp. alesti. J Gen Microbiol (1993) 1.22
UTP: alpha-D-glucose-1-phosphate uridylyltransferase of Escherichia coli: isolation and DNA sequence of the galU gene and purification of the enzyme. J Bacteriol (1994) 1.21
Cloning, sequencing, and phenotypic analysis of laf1, encoding the flagellin of the lateral flagella of Azospirillum brasilense Sp7. J Bacteriol (1995) 1.10
Generalized and mobilizable positive-selection cloning vectors. Gene (1994) 1.10
Molecular analysis of a flagellar core protein gene of Serpulina (Treponema) hyodysenteriae. J Gen Microbiol (1993) 1.07
A cold-regulated cyanobacterial gene cluster encodes RNA-binding protein and ribosomal protein S21. Plant Mol Biol (1994) 1.06
Molecular genetic analysis of a class B periplasmic-flagellum gene of Treponema phagedenis. J Bacteriol (1992) 1.01
Molecular analysis of a Leptospira borgpetersenii gene encoding an endoflagellar subunit protein. J Gen Microbiol (1991) 1.01
Nucleotide sequence of the Wolinella succinogenes flagellin, which contains in the antigenic domain two conserved regions also present in Campylobacter spp. and Helicobacter pylori. J Bacteriol (1994) 0.87
Flagellar structure and hyperthermophily: analysis of a single flagellin gene and its product in Aquifex pyrophilus. J Bacteriol (1995) 0.85
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol (1998) 5.34
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother (1999) 4.29
A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis (1979) 4.27
Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc Natl Acad Sci U S A (1982) 3.89
Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis (1987) 3.79
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells. J Infect Dis (1981) 3.51
Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun (1980) 3.23
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun (1982) 2.76
Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol (1999) 2.72
Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J Infect Dis (1979) 2.70
Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect (1997) 2.69
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog (2001) 2.52
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol (1998) 2.46
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol (1984) 2.23
Development of the Woman Abuse Screening Tool for use in family practice. Fam Med (1996) 2.03
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Demonstration of an iron-siderophore-binding protein in the outer membrane of Pseudomonas aeruginosa. Infect Immun (1983) 1.82
Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis (1983) 1.77
Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun (1994) 1.77
Broad-host-range cloning and cassette vectors based on the R388 trimethoprim resistance gene. Biotechniques (1996) 1.70
Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun (1999) 1.70
Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun (1989) 1.70
Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun (1996) 1.70
Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob Agents Chemother (1989) 1.69
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol (1986) 1.60
Clostridium sordellii infection and toxin neutralization. Pediatr Infect Dis J (1990) 1.53
Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol (1993) 1.52
Complete primary structure for the zymogen of human complement factor B. J Biol Chem (1984) 1.48
Current studies on the pathogenesis of melioidosis. Microbes Infect (1999) 1.42
Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest (1981) 1.40
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38
Pathogenesis of and immunity to melioidosis. Acta Trop (2000) 1.38
Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun (1991) 1.30
Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei. J Bacteriol (1999) 1.29
Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis (1980) 1.28
Purification of Pseudomonas aeruginosa exoenzyme S. Infect Immun (1987) 1.28
Syrian hamster female protein: analysis of female protein primary structure and gene expression. Science (1985) 1.28
An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology (2003) 1.27
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother (1999) 1.25
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis (1985) 1.23
Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B. Isolation and nucleotide sequencing of mouse factor B cDNA clones. J Biol Chem (1983) 1.23
A controlled field trial of group versus individual cognitive-behavioural training for relapse prevention. Addiction (1996) 1.20
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. N Engl J Med (1984) 1.19
Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun (1997) 1.18
Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog (1988) 1.18
Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun (1997) 1.14
Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa. Infect Immun (1986) 1.13
Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. J Clin Invest (1984) 1.13
Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol (1996) 1.12
Purification and characterization of a protease from Pseudomonas pseudomallei. Can J Microbiol (1994) 1.07
Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur J Clin Microbiol (1985) 1.07
Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science (1983) 1.02
Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis (1999) 1.01
Lung bacterial clearance in murine pneumococcal pneumonia. Infect Immun (1977) 1.01
Isolation and characterization of the outer-membrane proteins of Burkholderia (Pseudomonas) pseudomallei. Microbiology (1994) 1.00
Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model. J Antimicrob Chemother (1989) 1.00
Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia. J Infect Dis (2000) 1.00
Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J Clin Invest (1993) 1.00
The isolation and characterization of cDNA clones for human apolipoprotein CII. J Biol Chem (1984) 0.98
Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol (1984) 0.97
Immunological cross-reactivity of a Mycoplasma pneumoniae membrane-associated protein antigen with Mycoplasma genitalium and Acholeplasma laidlawii. J Clin Microbiol (1987) 0.97
Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin Invest Med (1994) 0.97
Biosynthesis and postsynthetic processing of human C-reactive protein. J Immunol (1983) 0.97
Antibody inhibition of ferripyochelin binding to Pseudomonas aeruginosa cell envelopes. Biochemistry (1984) 0.97
Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. J Biol Chem (1985) 0.96
Monoclonal antibodies to Pseudomonas aeruginosa ferripyochelin-binding protein. Infect Immun (1986) 0.95
Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med (1999) 0.95
Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol (1993) 0.94
Cloning and expression of the Pseudomonas aeruginosa exoenzyme S toxin gene. Microb Pathog (1990) 0.94
Modulatory effect of iron on the pathogenesis of Pseudomonas aeruginosa mouse corneal infections. Infect Immun (1982) 0.93
Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect Immun (1995) 0.93
In vivo-induced genes in Pseudomonas aeruginosa. Infect Immun (2000) 0.92
Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines. Infect Immun (2000) 0.91
The mobilization of maternal histone messenger RNA after fertilization of the sea urchin egg. Cell Differ (1978) 0.90
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection. J Infect Dis (1993) 0.87
Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity. Microbiology (2000) 0.87
Involvement of the MyD88-independent pathway in controlling the intracellular fate of Burkholderia pseudomallei infection in the mouse macrophage cell line RAW 264.7. Microbiol Immunol (2010) 0.85
Factors influencing the adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Rev Infect Dis (1984) 0.84
Exoenzyme S from Pseudomonas aeruginosa induces apoptosis in T lymphocytes. J Leukoc Biol (2000) 0.84
Production of an extracellular toxic complex by various strains of Pseudomonas cepacia. J Med Microbiol (1989) 0.83
Role of Pseudomonas aeruginosa extracellular enzymes in lung disease. Clin Invest Med (1986) 0.83
Dissemination of Pseudomonas aeruginosa during lung infection in hamsters. Role of oxygen-induced lung injury. Am Rev Respir Dis (1985) 0.82
Diffuse lamellar keratitis: isolation of endotoxin and demonstration of the inflammatory potential in a rabbit laser in situ keratomileusis model. J Cataract Refract Surg (2001) 0.82
Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro. Infect Immun (1999) 0.81
The importance of extracellular antigens in Pseudomonas cepacia infections. J Med Microbiol (1988) 0.81
Alteration of lung structure and function by Pseudomonas aeruginosa. Pathol Immunopathol Res (1987) 0.80
The effects of purified 25-kDa lipase from a clinical isolate of Pseudomonas cepacia in the lungs of rats. Curr Microbiol (1992) 0.80
Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis. Hybridoma (1993) 0.80